Adamas Pharmaceuticals Inc. buy Quitte
Start price
23.12.15
/
50%
€20.62
Target price
06.01.16
€23.36
Performance (%)
12.12%
End price
06.01.16
€23.12
Summary
This prediction ended on 06.01.16 with a price of €23.12. The BUY prediction by Quitte finished with a performance of 12.12%. Quitte has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Adamas Pharmaceuticals Inc. | - | - | - | - |
| iShares Core DAX® | 1,35 % | 2,74 % | 7,87 % | 51,84 % |
| iShares Nasdaq 100 | 3,28 % | 6,51 % | 41,46 % | 93,77 % |
| iShares Nikkei 225® | 7,43 % | 17,83 % | 69,10 % | 79,07 % |
| iShares S&P 500 | 1,70 % | 3,10 % | 27,31 % | 67,28 % |
Comments by Quitte for this prediction
In the thread Adamas Pharmaceuticals Inc. diskutieren
Erfolge bei Parkinson
Adamas Pharma: Phase-3-Studie zu ADS-5102 erzielt gewünschte Resultate
(Stop Loss Kurs erreicht)

